Published in Am J Respir Crit Care Med on October 01, 1995
Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol (2002) 6.37
Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev (2001) 3.33
The role of interferon in influenza virus tissue tropism. J Virol (1998) 2.88
Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci (2001) 2.41
The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc (2006) 1.96
Substrate cleavage analysis of furin and related proprotein convertases. A comparative study. J Biol Chem (2008) 1.40
Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J Virol (2008) 1.37
The highly pathogenic H7N3 avian influenza strain from July 2012 in Mexico acquired an extended cleavage site through recombination with host 28S rRNA. Virol J (2013) 1.33
Influenza virus hemagglutinin cleavage into HA1, HA2: no laughing matter. Proc Natl Acad Sci U S A (1998) 1.28
Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol (2010) 1.16
Role of proteases in the release of porcine epidemic diarrhea virus from infected cells. J Virol (2011) 1.14
The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol (2014) 1.05
RNA Viruses: ROS-Mediated Cell Death. Int J Cell Biol (2014) 1.01
Cleavage of influenza A virus H1 hemagglutinin by swine respiratory bacterial proteases. J Virol (1997) 0.98
Isolation and characterization of highly pathogenic avian influenza virus subtype H5N1 from donkeys. J Biomed Sci (2010) 0.95
Selective and potent furin inhibitors protect cells from anthrax without significant toxicity. Int J Biochem Cell Biol (2010) 0.84
The replication of Bangladeshi H9N2 avian influenza viruses carrying genes from H7N3 in mammals. Emerg Microbes Infect (2016) 0.76
Characterization of an H4N2 influenza virus from Quails with a multibasic motif in the hemagglutinin cleavage site. Virology (2014) 0.76
TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus. Sci Rep (2016) 0.75
Avian influenza: should China be alarmed? Yonsei Med J (2007) 0.75
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med (1999) 9.23
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med (2001) 7.49
Complete genome sequence of an aerobic hyper-thermophilic crenarchaeon, Aeropyrum pernix K1. DNA Res (1999) 7.39
Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3. DNA Res (1998) 6.79
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34
Fetal growth and perinatal viability in California. Obstet Gynecol (1982) 5.23
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J (1992) 5.05
Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85
Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill (2013) 4.44
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature (1992) 4.16
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother (2003) 3.90
Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med (2000) 3.74
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
Tadpole collagenase. Preparation and purification. Biochemistry (1966) 3.50
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A (2001) 3.43
Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41
In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol (1981) 3.34
The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology (1979) 3.25
A glycolipid on the surface of mouse natural killer cells. Eur J Immunol (1980) 3.13
Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol (2000) 3.10
Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science (2001) 3.08
p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J (1993) 3.06
Complete genome sequence of an aerobic thermoacidophilic crenarchaeon, Sulfolobus tokodaii strain7. DNA Res (2001) 2.99
Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells. J Virol (1976) 2.91
Automated analysis of protein NMR assignments using methods from artificial intelligence. J Mol Biol (1997) 2.86
Inhibition of glycoprotein biosynthesis of influenza virus by D-glucosamine and 2-deoxy-D-glucose. Virology (1972) 2.84
Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. EMBO J (1995) 2.76
Influenza viruses cause hemolysis and fusion of cells. Virology (1981) 2.73
Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells. Proc Natl Acad Sci U S A (1970) 2.73
The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J (1997) 2.71
Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells. J Virol (1971) 2.68
Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci U S A (1965) 2.61
Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology (1983) 2.53
The proteins of the parainfluenza virus SV5. 1. Separation of virion polypeptides by polyacrylamide gel electrophoresis. Virology (1969) 2.50
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
Lipids of plasma membranes of monkey and hamster kidney cells and of parainfluenza virions grown in these cells. Virology (1969) 2.48
Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology (1987) 2.46
Molecular biology and evolution of filoviruses. Arch Virol Suppl (1993) 2.45
A woman who trembled, then had chorea. Lancet (1998) 2.40
Interactions of Marburg virus nucleocapsid proteins. Virology (1998) 2.37
The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion. Virology (1970) 2.37
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol (1996) 2.26
How to overcome resistance of influenza A viruses against adamantane derivatives. Antiviral Res (1998) 2.25
Pause on avian flu transmission research. Science (2012) 2.24
Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology (2000) 2.21
Recovery of pathogenic measles virus from cloned cDNA. J Virol (2000) 2.19
Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein. J Virol (1994) 2.17
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17
Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem (1992) 2.13
Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology (1981) 2.13
PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex. Genes Cells (2001) 2.13
Natural and experimental Borna disease in animals. Curr Top Microbiol Immunol (1995) 2.11
Glycosylation and oligomerization of the spike protein of Marburg virus. Virology (1991) 2.11
Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol (2000) 2.09
Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J Virol (1997) 2.09
Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J (2000) 2.08
Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie (1994) 2.07
Association of influenza virus proteins with cytoplasmic fractions. Virology (1974) 2.00
Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology (1977) 2.00
Therapeutic abortions in California. Calif Med (1971) 1.98
Studies on the adaptation of influenza viruses to MDCK cells. EMBO J (1984) 1.98
Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. EMBO J (1986) 1.98
The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97
Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96
Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem (1986) 1.92
Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett (1999) 1.92
A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol (2000) 1.92
Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J Virol (1992) 1.91
Infection and activation of monocytes by Marburg and Ebola viruses. J Virol (2001) 1.90
An electron microscopic study of the presence or absence of neuraminic acid in enveloped viruses. Virology (1970) 1.88
The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Arch Virol Suppl (1999) 1.87
Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J Virol (1993) 1.85
Biosynthesis and role of filoviral glycoproteins. J Gen Virol (2001) 1.84
Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology (1989) 1.81
Marburg and Ebola viruses. Adv Virus Res (1996) 1.81
Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3 (supplement). DNA Res (1998) 1.81
Inhibition of glycosylation of the influenza virus hemagglutinin. J Virol (1974) 1.81
Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol (1986) 1.80
Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J Cell Biol (1994) 1.80
Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J Virol (2000) 1.79
Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology (1992) 1.79
Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus. J Mol Biol (2000) 1.79
The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J (1985) 1.76
A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis. Anal Biochem (1972) 1.76
The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol (1995) 1.76
Fusion between cell membrane and liposomes containing the glycoproteins of influenza virus. Virology (1980) 1.73
Release of viral glycoproteins during Ebola virus infection. Virology (1998) 1.73
Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71